Drug interaction study for older people with HIV
Part of Cancer, Heart & circulation, Hormones & metabolism, Immune system & allergy, Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how other medicines you take for conditions like high blood pressure, diabetes, or cholesterol might interact with your HIV medication (Biktarvy) if you are 60 or older. The goal is to learn how to better manage your overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older.
- You have HIV and are currently taking a medication called Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide).
- You have at least one other health condition (like high blood pressure, diabetes, or cholesterol) for which you take medication.
- You have never had a test showing that your HIV is resistant to the medicines in Biktarvy.
- You do not have a serious acute infection right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with well-controlled HIV who are planning to switch to a long-acting HIV medicine given as injections. It may help researchers understand how this approach works for people already stable on current treatment.
This study tests whether people with both HIV and hepatitis B (HBV) can safely stop or switch parts of their antiviral treatment. It aims to see if simpler treatment can keep both viruses under control for 96 weeks.
This study tests a faster way to switch to a modern HIV medication (Biktarvy) in people who have recently moved to Quebec and are already on HIV treatment. The goal is to see if this quick switch helps keep the virus under control with fewer clinic visits.
This study looks at how taking multiple medicines (called polypharmacy) might affect healthy aging in people with HIV who are 75 or older. It aims to understand how to better manage medications for older adults with HIV.
This study measures the “hidden” HIV reservoir in the body and how it relates to blood levels of antiretroviral medicines. It may help doctors better understand why HIV can remain even when the virus is controlled.
This study tests a newer HIV medication, B/F/TAF, as a first-line treatment. It compares B/F/TAF with older combinations (TDF+3TC+EFV or DTG/3TC) to see how well it works for people who have never taken HIV meds.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.